Series B Funded Startups in Switzerland
The largest disclosed Series B in this Switzerland slice is Noema Pharma’s $147M round on 2024-12-11, which dwarfs most other disclosed rounds (e.g., Grani…
The largest disclosed Series B in this Switzerland slice is Noema Pharma’s $147M round on 2024-12-11, which dwarfs most other disclosed rounds (e.g., Granite Bio at $70M on 2025-04-24 and ImmunOs Therapeutics at $73M on 2022-06-07). At the smaller end, the lowest disclosed amount is $2M for 4D Lifetec on 2022-07-15, creating a wide disclosed range from $2M to $147M.
Round dates span 2021-07-19 (PriceHubble) through 2025-11-11 (Delvitech). Geography shows a hub pattern around Zürich-area listings: Zürich appears repeatedly across multiple companies (e.g., Auterion on 2025-09-24 for Zürich, ANYbotics on 2024-12-12 for Zürich, and Sygnum on 2022-01-06 for Zürich). Sector-wise, Biotechnology is one of the most frequent categories in these 50 rows (e.g., Granite Bio $70M on 2025-04-24; Noema Pharma $147M on 2024-12-11; ImmunOs Therapeutics $73M on 2022-06-07), while two rounds have undisclosed amounts (Wingtra 2024-08-15; Dufour Aerospace 2023-01-23).
Most recent rounds
50 shownRelated listings
Frequently asked
What’s the largest disclosed Series B amount in this Switzerland list, and how big is the gap versus the rest?
Noema Pharma’s $147M (2024-12-11) is the clear outlier on disclosed amounts; several notable rounds sit well below it, such as Granite Bio at $70M (2025-04-24) and ImmunOs Therapeutics at $73M (2022-06-07). The smallest disclosed round is 4D Lifetec at $2M (2022-07-15), widening the disclosed range to $2M–$147M.
Do any clusters show up in time within the 50 most recent rounds shown?
Yes. There’s a dense late-2024 window featuring multiple Series B closings in December (e.g., ANYbotics $60M on 2024-12-12, Embotech $26M on 2024-12-12, and Noema Pharma $147M on 2024-12-11). Another concentration appears in early-2025, with several rounds landing between February and June 2025 (e.g., AMNIS Treasury Services $10M on 2025-02-26; Sparta $42M on 2025-02-24; Hilo $42M on 2025-05-01; Granite Bio $70M on 2025-04-24).
Which city shows the most repeated presence, and are there repeated naming variants?
Zürich is the most consistently recurring city label across the list, appearing for companies such as Auterion ($105M on 2025-09-24), ANYbotics ($60M on 2024-12-12), and Sygnum ($90M on 2022-01-06). There are also variations like Zürich, Zurich (e.g., Boost 2025-06-26 $20M) and Zürich (e.g., Daedalean 2022-01-17 $58M), but the pattern still centers on the Zürich area.
Are any sectors over-represented, and does the largest disclosed round fit that mix?
Biotechnology appears repeatedly, including Granite Bio ($70M on 2025-04-24), Noema Pharma ($147M on 2024-12-11), and ImmunOs Therapeutics ($73M on 2022-06-07). Notably, the single largest disclosed round ($147M) is also Biotechnology (Noema Pharma), aligning the top of the disclosed distribution with that sector.
Are undisclosed amounts material to the analysis here, and where do they occur?
Two entries list undisclosed round amounts: Wingtra on 2024-08-15 and Dufour Aerospace on 2023-01-23. Because comparisons above and below depend on disclosed figures, these two rounds are out of bounds for identifying the largest and smallest disclosed amounts.
Which entries are at the temporal edges of the 50 rows shown, and what does that imply about recency?
The most recent round in the dataset window is Delvitech on 2025-11-11 ($40M), while the oldest is PriceHubble on 2021-07-19 ($34M). That four-year span suggests the list mixes older and newer cohorts rather than focusing only on the last few quarters.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.